A pilot study on the safety and efficacy of generic mycophenolate agent as conversion maintenance therapy in stable liver transplant recipients

Transplantation Proceedings

Volumn 45, Issue 8, 2013, Pages 3035-3037

  Namgoong, J M ^a   Hwang, S ^a   Ahn, C S ^a   Kim, K H ^a   Moon, D B ^a   Ha, T Y ^a   Song, G W ^a   Jung, D H ^a   Park, G C ^a   Park, H W ^a   Park, C S ^a   Park, Y H ^a   Kang, S H ^a   Jung, B H ^a   Lee, S G ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MYCONOL; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; AGED; CONFERENCE PAPER; DIARRHEA; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; GRAFT RECIPIENT; HUMAN; INDIGESTION; INSOMNIA; KOREA; LIVER FUNCTION; LIVER TRANSPLANTATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; OUTPATIENT; PILOT STUDY; PRIORITY JOURNAL; PRURITUS; RASH;

DRUGS, GENERIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MYCOPHENOLIC ACID; PILOT PROJECTS; REPUBLIC OF KOREA;

EID: 84886251446     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.08.026     Document Type: Conference Paper

References (9)

1. M. Masri The generics in transplantation and the rules on their use Exp Clin Transplant 1 2003 65
2. C.R. Ensor, J. Trofe-Clark, and S. Gabardi Generic maintenance immunosuppression in solid organ transplant recipients Pharmacotherapy 31 2011 1111
3. S. Sudhindran, S. Aboobacker, and R.N. Menon Cost and efficacy of immunosuppression using generic 6 products following living donor liver transplantation in India Indian J Gastroenterol 31 2012 20
4. B. Rutkowski, B. Bzoma, and A. Debska-Slizien Immunosuppressive regimens containing generic mycophenolate mofetil (Myfenax) in de novo renal transplant recipients - preliminary results of 6-month observation Ann Transplant 16 2011 74
5. S. Hwang, S.G. Lee, and C.S. Ahn A clinical assessment of mycophenolate drug monitoring after liver transplantation Clin Transplant 24 2010 E35
6. S. Patel, V. Chauhan, and J. Mandal Single-dose, two-way crossover, bioequivalence study of Mycophenolate mofetil 500 mg tablet under fasting conditions in healthy male subjects Clin Ther 33 2011 378
7. S. Almeida, A. Filipe, and R. Neves Mycophenolate mofetil 500-mg tablet under fasting conditions: single-dose, randomized-sequence, open-label, four-way replicate crossover, bioequivalence study in healthy subjects Clin Ther 32 2010 556
8. M.A. Masri, S. Rizk, and M.L. Attia Bioavailability of a new generic formulation of mycophenolate mofetil MMF 500 versus CellCept in healthy adult volunteers Transplant Proc 39 2007 1233
9. C. Videla, and C. Godoy Converting to a generic formulation of mycophenolate mofetil in stable kidney transplant recipients: 1 year of drug surveillance and outcome Transplant Proc 39 2007 602